Generating a Novel Bispecific Nanobody to Enhance Antitumor Activity
Tumor cells express high levels of human epidermal growth factor receptor 2 (HER2) and vascular endothelial growth factor receptor 2 (VEGFR2), which are closely related to their proliferation and survival. Cancer treatments that target a single signaling pathway may result in immune pathway escape o...
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | English |
| Publicado: |
Georg Thieme Verlag KG
2020-06-01
|
| Series: | Pharmaceutical Fronts |
| Subjects: | |
| Acceso en liña: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1714138 |